SCHEMBL4862714

SCHEMBL4862714

Cc1cc(C)c2nc(NNC(=O)[C@]3(CN(O)C=O)CC[C@H](C)CC3)nnc2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4862460 0.88 SRC (0.31)
SCHEMBL4870712 0.86 KDM4E (0.31)
SCHEMBL4867355 0.78 KDM4E (0.30)
SCHEMBL4861448 0.77 P2RX7 (0.34)
SCHEMBL4869256 0.76 SRC (0.31)
SCHEMBL4868061 0.76 LMNA (0.30)
SCHEMBL4864187 0.76 P2RX7 (0.32)
SCHEMBL4866372 0.76 POLB (0.35)
SCHEMBL4864460 0.75
SCHEMBL4862729 0.75 MAPT (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332485-B2 Peptide deformylase inhibitors SMITHKLINE BEECHAM CORP (US) 2008-02-19 US claimed
US-20060160802-A1 Peptide deformylase inhibitors GLAXO GROUP LIMITED 2006-07-20 US claimed
US-7332485-B2 Peptide deformylase inhibitors SMITHKLINE BEECHAM CORP (US) 2008-02-19 US disclosed
US-20060160802-A1 Peptide deformylase inhibitors GLAXO GROUP LIMITED 2006-07-20 US disclosed